Increased plasma levels of neuropeptide Y in hepatorenal syndrome

Journal of Hepatology

Volumn 36, Issue 3, 2002, Pages 349-355

  Uriz, Juan ^a,b,c   Ginès, Pere ^a,b,c   Ortega, Rolando ^a,b,c   Jiménez, Wladimiro ^a,b,c   Cárdenas, Andrés ^a,b,c   Calahorra, Blas ^a,b,c   Sort, Pau ^a,b,c   Fernández, Javier ^a,b,c   Bataller, Ramón ^a,b,c   Arroyo, Vicente ^a,b,c   Rivera, Francisca ^a,b,c   Rodés, Juan ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Inst Reina Sofia Invest N   (Spain)

Author keywords

Ascites; Cirrhosis; Hepatorenal syndrome; Levels; Neuropeptide Y

Indexed keywords

ALBUMIN; NEUROPEPTIDE Y; NORADRENALIN; TERLIPRESSIN; VASOCONSTRICTOR AGENT;

ADRENERGIC SYSTEM; ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; LIVER CIRRHOSIS; MALE; NERVE STIMULATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ASCITES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEPATORENAL SYNDROME; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NEUROPEPTIDE Y; NOREPINEPHRINE; RENAL CIRCULATION; VASOCONSTRICTION;

EID: 0036189529     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00286-0     Document Type: Article

References (48)

1. The hepatorenal syndrome
2. Hepatorenal syndrome
3. The sympathetic nervous system in cirrhosis
4. Hepatorenal disorders: Role of the sympathetic nervous system
5. Ascites and hepatorenal syndrome during cirrhosis: Two entities or the continuation of the same complications?
6. Sympathetic nervous activity in cirrhosis: A survey of plasma catecholamines studies
7. Autonomic nervous function in liver disease
8. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome
9. Reversibility of hepatorenal syndrome by prolonged administración of ornipressin and plasma volume expansion
10. Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome
11. Neural control of renal function
12. Peptides as neurotransmitters in vascular autonomic neurons
13. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control
14. Renal effects of neuropeptide Y
15. Neuropeptide Y: A possible role in hypertension?
16. Neuropeptide Y and regulation of the cardiovascular system
17. Neuropeptide Y and cardiovascular regulation
18. Cardiovascular effects of neuropeptide Y: Receptor interactions and cellular mechanisms
19. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
20. A new method for the determination of inulin in plasma and urine
21. A rapid method for the determination of para-aminohippuric acid and kidney function test
22. Clinical disorders of renal function in cirrhosis with ascites
23. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document
24. Assessment of the renin-angiotensin system in cirrhotic patients: Comparison between plasma renin activity and direct measurement of immunoreactive renin
25. The nerves of the juxta- glomeruta apparatus of man and other mammals contain the potent peptide NPY
26. Localization of neuropeptide Y and it's C- terminal flanking peptide in human renal tissue
27. Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in rat kidney
28. Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal peptide, substance P, calcitonin gene-related peptide, somatostatin) inmunohistochemistry and ultrastructure of renal nerves
29. The role of neuropeptide Y in cardiovascular regulation
30. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and function expression of the receptors
31. Expression of the human neuropeptide tyrosine Y1 receptor
32. Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit
33. Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: Non-uniform pattern of vascular reactivity
34. Differencial effect of neuropeptide Y on membrane potencial of cells in renal arterioles of the hydronephrotic mouse
35. Vasoconstricition of rat renal interlobar arteries by noradrenaline and neuropeptide Y
36. Similarities and differences in the pstjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature
37. Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: Maintained overflow of neuropeptide Y in controls but not after reserpine
38. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226
39. SR 120107 A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo
40. Pathogenesis and management of hepatorenal syndrome
41. The renin-angiotensin-aldosterone system in cirrhosis
42. Plasma endothelin immunoreactivity in liver disease and hepatorenal syndrome
43. Neuroendocrinology of chronic renal failure and renal transplantation
44. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment
45. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure
46. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis
47. Noradrenalin and adrenalin concentrations in various vascular beds in patients with cirrhosis: Relation to hemodynamics
48. Elevated plasma norepinephrine concentrations in descompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion